Drug Shortage Report for EPIPEN
| Report ID | 31606 |
| Drug Identification Number | 00509558 |
| Brand name | EPIPEN |
| Common or Proper name | EPIPEN |
| Company Name | MYLAN SPECIALTY LP |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | Each (0.3MG/0.3ML AUTO-INJECTOR) |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-12-04 |
| Estimated end date | 2018-03-23 |
| Actual end date | 2018-03-09 |
| Shortage status | Resolved |
| Updated date | 2018-03-10 |
| Company comments | Inventory released on Feb 26, 2018 to replenish market. Remaining inventory on preventative allocation. Additional inventory expected week of March 19, 2018. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3711 COLLINS FERRY ROAD MORGANTOWN, WEST VIRGINIA UNITED STATES 26505 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-12-04 | English | Compare |